Loading…
Sectoral / Thematic · Nippon India Mutual Fund · AMFI code 102431Nippon India Pharma Fund
Disclosed for 84 months, Sep 2019 to Aug 2026.Published as: NIPPON INDIA PHARMA FUND (An Open Ended Equity Scheme Investing In Pharma Sector)
Portfolio value
₹7,404 Cr
up ₹243 Cr vs May 2024
- Stocks held
- 31
- unchanged
- Top 10 weight
- 61.2%
- of the portfolio in its ten largest
- Cash & debt
- 0.6%
- cash, money market and debt
- Moves this month
- 1 in · 1 out
- added to 10, trimmed 9
Nippon India Pharma Fund is an active equity fund in the Sectoral / Thematic category from Nippon India Mutual Fund. In June 2024 it disclosed 31 stocks worth ₹7,404 Cr, up ₹243 Cr from May 2024. Its largest positions were Sun Pharmaceutical Industries Limited (13.5%), Divi's Laboratories Limited (8.4%), Lupin Limited (7.7%); the ten largest together made up 61.2% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 78.7% of its equity. Cash and debt stood at 0.6%. Compared with May 2024 the fund entered 1 new stock and exited 1.
Against 226 other Sectoral / Thematic funds
Concentration
85%
Top-10 weight is higher than 85% of peers
Breadth
16%
Holds more stocks than 16% of peers
Cash
7%
Holds more cash than 7% of peers
Holdings in June 2024
Download CSVEvery line the fund disclosed, with the change against May 2024. Click a column to sort; click a company to see every fund that owns it.
- Weight
- 13.47%
- Δ weight
- up 0.10 pts
- Value
- ₹997 Cr
- Δ value
- up ₹40 Cr
- Status
- Added
- Weight
- 8.39%
- Δ weight
- up 0.86 pts
- Value
- ₹621 Cr
- Δ value
- up ₹82.1 Cr
- Status
- Added
- Weight
- 7.67%
- Δ weight
- down 0.07 pts
- Value
- ₹568 Cr
- Δ value
- up ₹13.6 Cr
- Status
- Added
- Weight
- 6.20%
- Δ weight
- down 0.07 pts
- Value
- ₹459 Cr
- Δ value
- up ₹10.4 Cr
- Status
- Added
- Weight
- 6.05%
- Δ weight
- up 1.60 pts
- Value
- ₹448 Cr
- Δ value
- up ₹130 Cr
- Status
- Added
- Weight
- 5.42%
- Δ weight
- up 0.13 pts
- Value
- ₹401 Cr
- Δ value
- up ₹22.5 Cr
- Status
- Added
- Weight
- 3.92%
- Δ weight
- up 0.15 pts
- Value
- ₹290 Cr
- Δ value
- up ₹19.9 Cr
- Status
- Added
- Weight
- 3.70%
- Δ weight
- down 0.67 pts
- Value
- ₹274 Cr
- Δ value
- down ₹39.1 Cr
- Status
- Trimmed
- Weight
- 3.22%
- Δ weight
- up 0.10 pts
- Value
- ₹239 Cr
- Δ value
- up ₹15 Cr
- Status
- Added
- Weight
- 3.20%
- Δ weight
- down 0.39 pts
- Value
- ₹237 Cr
- Δ value
- down ₹20.5 Cr
- Status
- Trimmed
- Weight
- 3.03%
- Δ weight
- down 0.13 pts
- Value
- ₹224 Cr
- Δ value
- down ₹2.2 Cr
- Status
- Trimmed
- Weight
- 2.98%
- Δ weight
- down 0.14 pts
- Value
- ₹221 Cr
- Δ value
- down ₹2.9 Cr
- Status
- Trimmed
- Weight
- 2.96%
- Δ weight
- down 0.19 pts
- Value
- ₹219 Cr
- Δ value
- down ₹6.5 Cr
- Status
- Trimmed
- Weight
- 2.94%
- Δ weight
- down 0.04 pts
- Value
- ₹217 Cr
- Δ value
- up ₹3.9 Cr
- Status
- Added
- Weight
- 2.84%
- Δ weight
- down 0.31 pts
- Value
- ₹210 Cr
- Δ value
- down ₹15 Cr
- Status
- Trimmed
- Weight
- 2.59%
- Δ weight
- down 0.10 pts
- Value
- ₹192 Cr
- Δ value
- down ₹95 L
- Status
- Held
- Weight
- 2.44%
- Δ weight
- down 0.05 pts
- Value
- ₹181 Cr
- Δ value
- up ₹2.3 Cr
- Status
- Added
- Weight
- 2.27%
- Δ weight
- up <0.01 pts
- Value
- ₹168 Cr
- Δ value
- up ₹5.7 Cr
- Status
- Added
- Weight
- 2.02%
- Δ weight
- down 0.82 pts
- Value
- ₹150 Cr
- Δ value
- down ₹53.9 Cr
- Status
- Trimmed
- Weight
- 1.95%
- Δ weight
- down 0.10 pts
- Value
- ₹144 Cr
- Δ value
- down ₹2.6 Cr
- Status
- Trimmed
- Weight
- 1.87%
- Δ weight
- up 0.01 pts
- Value
- ₹138 Cr
- Δ value
- up ₹5 Cr
- Status
- Added
- Weight
- 1.80%
- Δ weight
- down 0.06 pts
- Value
- ₹133 Cr
- Δ value
- up ₹7 L
- Status
- Held
- Weight
- 1.60%
- Δ weight
- up 0.02 pts
- Value
- ₹118 Cr
- Δ value
- up ₹5.6 Cr
- Status
- Added
- Weight
- 1.52%
- Δ weight
- up 0.01 pts
- Value
- ₹113 Cr
- Δ value
- up ₹4.4 Cr
- Status
- Added
- Weight
- 1.11%
- Δ weight
- up 0.10 pts
- Value
- ₹82.3 Cr
- Δ value
- up ₹9.9 Cr
- Status
- Added
- Weight
- 1.09%
- Δ weight
- up 1.09 pts
- Value
- ₹80.6 Cr
- Δ value
- up ₹80.6 Cr
- Status
- New
- Weight
- 1.08%
- Δ weight
- up 0.02 pts
- Value
- ₹79.9 Cr
- Δ value
- up ₹4.3 Cr
- Status
- Added
- Weight
- 0.80%
- Δ weight
- up 0.04 pts
- Value
- ₹59.6 Cr
- Δ value
- up ₹4.5 Cr
- Status
- Added
- Cash, TREPS & receivables
- Weight
- 0.56%
- Δ weight
- down 1.06 pts
- Value
- ₹41.4 Cr
- Δ value
- down ₹74.5 Cr
- Status
- Trimmed
- Weight
- 0.54%
- Δ weight
- down 0.01 pts
- Value
- ₹40.1 Cr
- Δ value
- up ₹46 L
- Status
- Added
- Weight
- 0.46%
- Δ weight
- up 0.26 pts
- Value
- ₹34.2 Cr
- Δ value
- up ₹19.8 Cr
- Status
- Added
- Weight
- 0.31%
- Δ weight
- down 0.20 pts
- Value
- ₹23.1 Cr
- Δ value
- down ₹13.6 Cr
- Status
- Trimmed
What changed, May 2024 to Jun 2024
New New positions (1)
- Sanofi Consumer Healthcare India Limited1.1% · ₹80.6 Cr
Exited Exited (1)
- Jubilant Pharmova Limitedwas 0.1% · ₹4.8 Cr
Added Biggest additions
- Dr. Reddy's Laboratories Limitedup ₹130 Cr (+1.60% pts)
- Divi's Laboratories Limitedup ₹82.1 Cr (+0.86% pts)
- Sun Pharmaceutical Industries Limitedup ₹40 Cr (+0.10% pts)
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since May 2024, the weight rose most in Pharmaceuticals & Biotechnology (+0.6 pts), and fell most in Retailing (−0.3 pts) and Healthcare Services (−0.2 pts).
- Pharmaceuticals & Biotechnology78.2% → 78.7%+0.6 pts
- Retailing3.2% → 2.9%−0.3 pts
- Healthcare Services17.9% → 17.6%−0.2 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | Jun 2021 | Jun 2023 | Dec 2023 | Mar 2024 | May 2024 | Jun 2024 |
|---|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 76.3% | 76.8% | 77.0% | 79.4% | 78.2% | 78.7% |
| Healthcare Services | 20.6% | 18.6% | 18.1% | 16.7% | 17.9% | 17.6% |
| Retailing | — | 3.1% | 3.6% | 3.1% | 3.2% | 2.9% |
| Pharmaceuticals | 2.3% | 1.2% | 1.1% | 0.9% | 0.8% | 0.8% |
Allocation in Jun 2024change vs May 2024
- Pharmaceuticals & Biotechnology (21)78.7%▲ 0.6 pts
- Healthcare Services (8)17.6%▼ 0.2 pts
- Retailing (1)2.9%▼ 0.3 pts
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal.
Cash & debt, Jun 2024
0.6%
▼ 1.1 pts vs May 2024
- Cash alone
- 0.6%
- cash and net receivables
- A year earlier
- 2.4%
- Jun 2023 · now ▼ 1.8 pts
- Last 12 months
- 0.5% – 3.9%
- lowest to highest · record 5.9% in May 2021
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.